Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02157610 · ClinicalTrials.gov registry record · NA
Smoking Cessation for Cervical Cancer Survivors
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 202
- Enrollment target
NCT02157610 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 202 participants.
The verdict
NCT02157610, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
Study Summary
The goal of this research study is to compare a program called Motivation And Problem-Solving (MAPS) to the standard treatment to help participants with a history of cervical cancer or high-grade cervical dysplasia quit smoking.
Interventions
- DRUG Nicotine Patch
- BEHAVIORAL Telephone Counseling Sessions
- BEHAVIORAL Self-Help Materials
- BEHAVIORAL REDCap
- PROCEDURE Saliva Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2015-01 |
| Est. Completion | 2021-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02157610
The ClinicalTrials.gov registry entry for NCT02157610 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Nicotine Patch is the first listed.
NCT02157610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02157610 about?
NCT02157610 is a clinical study titled "Smoking Cessation for Cervical Cancer Survivors". The goal of this research study is to compare a program called Motivation And Problem-Solving (MAPS) to the standard treatment to help participants with a history of cervical cancer or high-grade cervical dysplasia quit smoking.
What is the current status of trial NCT02157610?
This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2015-01. Estimated completion is 2021-08.
What interventions are being tested in trial NCT02157610?
The interventions under investigation include: Nicotine Patch (DRUG), Telephone Counseling Sessions (BEHAVIORAL), Self-Help Materials (BEHAVIORAL), REDCap (BEHAVIORAL), Saliva Test (PROCEDURE).
Who is sponsoring clinical trial NCT02157610?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.